about
Advanced drug delivery and targeting technologies for the ocular diseasesNanomedicine approaches for corneal diseasesNanostructured materials for ocular delivery: nanodesign for enhanced bioadhesion, transepithelial permeability and sustained deliveryLacritin-mediated regeneration of the corneal epithelia by protein polymer nanoparticlesIntraocular pressure changes: an important determinant of the biocompatibility of intravitreous implantssFlt Multivalent Conjugates Inhibit Angiogenesis and Improve Half-Life In VivoPharmaceutical intervention for myopia control.Solid lipid nanoparticles for ocular drug delivery.Antitumor activity of silver nanoparticles in Dalton's lymphoma ascites tumor model.Real-time monitoring of sustained drug release using the optical properties of porous silicon photonic crystal particles.Selection of a suitable method for the preparation of polymeric nanoparticles: multi-criteria decision making approachNanoengineering of therapeutics for retinal vascular disease.Ocular delivery of cyanidin-3-glycoside in liposomes and its prevention of selenite-induced oxidative stress.Biomedical Applications of Magnetically Functionalized Organic/Inorganic Hybrid Nanofibers.Prophylactic effect of topical silica nanoparticles as a novel antineovascularization agent for inhibiting corneal neovascularization following chemical burn.Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro.Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticlesNanotechnology in corneal neovascularization therapy--a reviewPreclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer.Nanoliposomal minocycline for ocular drug deliveryFabrication, functionalization, and application of electrospun biopolymer nanofibers.Recent perspectives in ocular drug delivery.Pharmacokinetics and tolerance study of intravitreal injection of dexamethasone-loaded nanoparticles in rabbits.Chitosan nanoparticles for drug delivery to the eye.Bacterial polyester inclusions engineered to display vaccine candidate antigens for use as a novel class of safe and efficient vaccine delivery agents.Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation.Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ1-42-induced oxidative stress.Flt23k nanoparticles offer additive benefit in graft survival and anti-angiogenic effects when combined with triamcinolone.Promising complexes of acetazolamide for topical ocular administration.Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.NANOTECHNOLOGY IN THE TREATMENT AND DETECTION OF INTRAOCULAR CANCERS.Ocular drug delivery - a look towards nanobioadhesives.A mini review of nanosuspensions development.Nanomaterials for ocular drug delivery.Impacts of nanomedicines in ocular pharmacotherapyDendrimers - from organic synthesis to pharmaceutical applications: an update.Breakdown of the blood-ocular barrier as a strategy for the systemic use of nanosystems.Topical delivery of ocular therapeutics: carrier systems and physical methods.Colloidal drug delivery system: amplify the ocular delivery.Microrobots: a new era in ocular drug delivery.
P2860
Q26747220-2447094B-4AA4-4C86-9E83-4A7DDF1E5966Q27022253-DA2450F0-39E9-4E0A-9A91-ACB4F0F9DB8AQ28088743-262DB5C9-4395-4C68-B0AC-D830A473863BQ28118688-2FD11980-5F43-40B4-B246-8171B9A4F566Q28478420-B4FA2DAD-9D9D-46E2-9964-C4099A6EA218Q28552652-7B2D464D-F253-4F05-98DE-4549B57DC455Q30472509-87595255-825F-44B5-B43D-EDC3AC654408Q34116807-F0A82236-DB8E-41FB-9A1D-29BF6977E606Q34231168-B56907E5-4AA2-4972-B87C-3A03AA113FD4Q34514512-B6C9905F-AEE6-4F6D-BEC7-3A8EBC1FD972Q35155304-04EFB425-5051-4175-92EF-FA9C51DF80AFQ35645705-7946C337-AAB5-4BA7-BB07-9EFD697130A6Q35783250-D66CEA04-F382-4090-9BE2-B48879634571Q35814073-DC241A5C-E981-462F-882B-6DD99FE38FD3Q35884453-856753EC-A85C-4C34-BECE-5A415B8B8794Q35991894-4B6546C0-92F2-4A47-9C99-11FA8235097DQ36297619-F062958C-1848-41E0-8CD5-D8ABE4071D3EQ36696450-385D6888-7885-4E22-9DA4-A16519A81AF3Q36962480-B59680B3-86B3-4ED3-98D2-6175113830E5Q37145338-63049625-FE31-442B-9A6D-93E3598B81FDQ37255791-FB9DA9B8-E87E-4D87-95A9-69EB49CC572AQ37256549-F75BF375-6806-4FDC-96A2-0848D827BAB4Q37354471-E00C480B-52B8-4F89-A689-10D84CF42FD2Q37416144-36FA2147-DBAA-4732-B770-C1298DF8F091Q37477387-436090F1-19B9-4112-9BD3-9A43898C4BC8Q37602017-48B07E72-CAE3-4780-A2D3-6518DABDAF49Q37631022-68A6C56D-F725-4765-81F8-7EB5A763912EQ37716548-FF9DE653-8DF2-47E7-B10F-902ED834ED03Q37766607-332C9EFF-2EF0-4498-ADE8-0CDA109234F9Q37769529-B3F1873A-4069-4F52-A542-411C5504A03AQ37776418-B3A0C48F-C9CE-45CC-AA45-E38868069965Q37822756-E5344A69-E3C8-482E-98C1-A9819CF101EBQ37970772-2698CFD8-4F7B-479B-AFFD-2913E05CF626Q38003088-042ED09C-53AD-4205-9F06-D7DD895D6138Q38107200-B30A8308-FFDE-4C3C-A003-522C905D6011Q38168279-9DA9C1D8-430D-412E-BF2C-B564EC7E6D39Q38168361-2F707409-47FC-43C5-B284-EDB9AEBD2447Q38196446-612034A6-F744-494C-A80C-2A09F9C1B0CAQ38217270-38BF2B85-7D17-429C-B130-AB0FB9ADF64EQ38227020-95D050A4-8BFD-46E6-BC90-D287E179411D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nanotechnology in ocular drug delivery.
@en
Nanotechnology in ocular drug delivery.
@nl
type
label
Nanotechnology in ocular drug delivery.
@en
Nanotechnology in ocular drug delivery.
@nl
prefLabel
Nanotechnology in ocular drug delivery.
@en
Nanotechnology in ocular drug delivery.
@nl
P2093
P1433
P1476
Nanotechnology in ocular drug delivery.
@en
P2093
Fahima Dilnawaz
S Krishnakumar
Sanjeeb K Sahoo
P304
P356
10.1016/J.DRUDIS.2007.10.021
P577
2008-02-01T00:00:00Z